eISSN: 2221-6197 DOI: 10.31301/2221-6197

Comparison of genetic markers of resistance and phenotypic profile of antimicrobial resistance in clinical isolates of Escherichia coli and Klebsiella pneumoniae.

Year: 2024

Pages: 369-380

Number: Volume 16, issue 4

Type: scientific article

Summary:

Bacteria of Enterobacteriaceae family are among the most common pathogens worldwide. The massive inappropriate use of antibiotics has led to the development and spread of multidrug resistance in them. Various mechanisms of resistance are now known and may be determined by antibiotic resistance genes. However, data of the spread of resistance genes among bacteria in the Russian Federation are scattered or absent. 
Methods. The isolates of E. coli and K. pneumoniae were obtained from KRIEM of Rospotrebnadzor. The sensitivity of clinical isolates to antibiotics was assessed using the disk diffusion method according to the recommendations of the International Association of Microorganisms of the Russian Federation (IACMAC). The presence of genetic markers of resistance in clinical isolates was determined using the polymerase chain reaction.
Results. Clinical isolates of E. coli and K. pneumoniae were resistant to different classes of antibiotics, and often one isolate was resistant to drugs of up to 3 classes. Meropenem was effective against the most of isolates. Only in some phenotypically resistant isolates the presence of common genetic markers mexB, mexD, ampC, aac(3)-IIa, aphA, aadB associated with antibiotic resistance was confirmed. This may call into question the relevance of using these markers to identify resistance genes.
Conclusion. Monitoring of the resistance genes spread is necessary to optimize the use of antibacterial drugs, taking into account the risks of horizontal transfer of genetic markers and to reduce the rate of their spread among pathogenic and opportunistic microorganisms. 

Keywords:

antibiotics. antibiotic resistance, Enterobacteriaceae, E. coli, K. pneumoniae

References:

1. Barbu I.C., Gheorghe-Barbu I., Grigore G.A., Vrancianu C.O., Chifiriuc M.C. Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical., Veterinary, and Aquatic Sectors // International Journal of Molecular Sciences. 2023. V. 24(9). 7892. doi:10.3390/ijms24097892 

2. Berrazeg M., Jeannot K., Ntsogo Enguene V. Y., Broutin L., Loeffert S., Fournier D., Plesiat P. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins // Antimicrobial agents and chemotherapy. 2015. V. 59(10). P.6248-6255. doi:10.1128/AAC.00825-15 

3. Diaz P.Q., Bello H.T., Dominguez M.Y., Trabal N.F., Mella S.M., Zemelman R.Z., Gonzalez G.R. Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de beta-lactamasas // Rev Med Chil. 2004. V. 132(10). P. 1173-1178. doi:10.4067/s0034-98872004001000003 

4. Du D. Wang-Kan X., Neuberger A., Veen H. W., Pos K. M., Piddock L. J. V., Luisi B. F. Multidrug efflux pumps: structure, function and regulation // Nature Reviews Microbiology. 2018. V.16. P.523-539. doi:10.1038/s41579-018-0048-6 

5. Gauba A., Rahman K.M., Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria // Antibiotics (Basel). 2023. V. 12(11). 1590. doi:10.3390/antibiotics12111590 

6. Khan R.T., Sharma V., Khan S.S., Rasool S. Prevention and potential remedies for antibiotic resistance: current research and future prospects // Front Microbiol. 2024. V. 3(15). 1455759. doi:10.3389/fmicb.2024.1455759 

7. Lakhundi S., Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology // Clin Microbiol. 2018. V. 31(4). e00020-18. doi:10.1128/cmr.00020-18. 

8. Martínez-Trejo A., Ruiz-Ruiz J.M., Gonzalez-Avila L.U., Saldana-Padilla A., Hernandez-Cortez C., Loyola-Cruz M. A., Bello-Lopez J. M., Castro-Escarpulli G. Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism // Int J Mol Sci. 2022. V. 23(12) 6582. doi:10.3390/ijms23126582 

9. Maynard C., Fairbrother J.M., Bekal S., Sanschagrin F., Levesque R.C., Brousseau R., Masson L., Lariviere S., Harel J. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs // Antimicrob Agents Chemother. 2003. V. 47(10). P. 3214-3221. doi:10.1128/AAC.47.10.3214-3221.2003 

10. Munita J.M., Arias C.A. Mechanisms of Antibiotic Resistance // Virulence Mechanisms of Bacterial Pathogens. 2016. P. 481–511. doi:10.1128/9781555819286.ch17 

11. Oliveira M., Antunes W., Mota S., Madureira-Carvalho A., Dinis-Oliveira R.J., Dias da Silva D. An Overview of the Recent Advances in Antimicrobial Resistance // Microorganisms. 2024. V. 12(9). 1920. doi:10.3390/microorganisms12091920

12. Saenz Y., Brinas L., Dominguez E., Ruiz J., Zarazaga M., Vila J., Torres C. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal., and food origins // Antimicrob Agents Chemother. 2004. V. 48(10). P. 3996-4001. doi:10.1128/AAC.48.10.3996-4001.2004 

13. Saenz Y., Brinas L., Dominguez E., Ruiz J., Zarazaga M., Vila J., Torres C. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal., and food origins // Antimicrob Agents Chemother. 2004. V. 48(10). P. 3996-4001. doi:10.1128/AAC.48.10.3996-4001.2004 

14. Softley C.A., Zak K.M., Bostock M.J., Fino R., Zhou R.X., Kolonko M., Mejdi-Nitiu R., Meyer H., Sattler M., Popowicz G. M. Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase // Antimicrobial Agents and Chemotherapy. 2020. V. 64(7). e01077-20. doi:10.1128/AAC.01077-20 

15. Terreni M., Taccani M., Pregnolato M. New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives // Molecules. 2021.V. 26(9). 2671. doi:10.3390/molecules26092671 

16. Thacharodi A., Lamont I. L. Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics // Antibiotics. 2022. V. 11(7). 884. doi:10.3390/antibiotics11070884 

17. Vasudevan A. Mohanalakshmi N., Dineshkumar K., Hopper W. Identification of inhibitors for RND efflux pump of Pseudomonas aeruginosa using structure - based pharmacophore modeling approach // International Journal of Pharmacy and Pharmaceutical Sciences. 2014. V.6. P.84–89. doi:10.1371/journal.pone.0101840 

18. Venter. H., Mowla R., Ohene-Agyei T., Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition // Front Microbiol. 2015. V. 6(18). 377. doi:10.3389/fmicb.2015.00377 

19. Xavier D.E., Picao R.C., Girardello R., Fehlberg L.C., Gales A.C. Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil // BMC Microbiol. 2010. V. 10. 217. doi:10.1186/1471-2180-10-217 

20. Yoneda K., Chikumi H., Murata T., Gotoh N., Yamamoto H., Fujiwara H., Nishini T., Shimizu E. Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction // FEMS Microbiol Lett. 2005. V. 243(1). P. 125-131. doi:10.1016/j.femsle.2004.11.048

Download pdf
up
eISSN: 2221-6197 DOI: 10.31301/2221-6197